Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer
Authors:
- Karen L. ChristmanKCKaren L. Christman
- Qizhi FangQFQizhi Fang
- Michael S. YeeMYMichael S. Yee
- Kandice R. JohnsonKJKandice R. Johnson
- Richard E. SieversRSRichard E. Sievers
- Randall J. LeeRLRandall J. Lee
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 26 (10) , 1139-1144
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina PectorisCirculation, 2002
- Therapeutic Angiogenesis in Critical Limb and Myocardial IschemiaJournal of Interventional Cardiology, 2001
- Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation studyJACC, 2000
- Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trialJACC, 2000
- VEGF Gene Delivery to MyocardiumCirculation, 2000
- Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formationJACC, 2000
- Epicardial gene therapy and laser revascularizationCurrent Cardiology Reports, 1999
- Six-Month Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNAAnnals of Surgery, 1999
- Angiogenesis Gene TherapyCirculation, 1999
- Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limbThe Lancet, 1996